NCT02026817View on ClinicalTrials.gov

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Diabetes Mellitus
Interventions
DRUG

HCP1201 750/10mg

750mg Metformin/10mg rosuvastatin fixed dose combination tablet orally in the morning on day1 or day8.

DRUG

Metformin SR 750mg

Co-administration of Metformin 750mg and Rosuvastatin 10mg orally in the morning on day1 or day8.

DRUG

Rosuvastatin 10mg

Co-administration of Metformin 750mg and Rosuvastatin 10mg orally in the morning on day1 or day8.

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02026817 - Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg | Biotech Hunter | Biotech Hunter